Bodal ChemicalsQ3 FY24

Bodal Chemicals Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹155.7P/E: 13.6Market Cap: ₹2.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

No

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • The company expects additional revenue of around Rs. 320 crores from the new benzene derivatives plant at optimum utilization by next year onwards.
  • Benzene derivatives segment aims to contribute roughly 25%-30% of overall topline with EBITDA margins of 12%-15%.
  • Capacity utilization for benzene derivatives is expected to ramp up to 50%-70% within 3-4 months and reach over 80% in subsequent months.
  • No major CAPEX planned for the next two years; generated cash flows will focus on debt repayment.
  • Dye intermediate revenue showed a 19% year-on-year growth in 9M FY24, indicating volume growth potential.
  • Caustic soda volumes grew by 25% in 9M FY24 despite price pressure; demand expected to remain healthy from FMCG, textile, and paper sectors.
  • Overall volumes and demand are gradually improving post multiple global headwinds, with December-January numbers better than previous quarters.

See what Bodal Chemicals management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes
  • No new expansion CAPEX is planned until business performance improves; current CAPEX (around Rs. 390 crore for benzene derivatives) to be completed within FY24.
  • All future cash flows post-CAPEX are planned to be used primarily for debt repayment.
  • Current gross debt stands at around Rs. 875 crore (Rs. 550 crore term debt + Rs. 325 crore working capital debt), with net debt about Rs. 800 crore.
  • Debt expected to be around Rs. 350 crore term debt by FY26 and working capital to remain at Rs. 300-350 crore.
  • Some non-core asset sale (land, factory in Ahmedabad valued at approx. Rs. 100 crore) is planned to reduce debt over the next 1 to 1.5 years.
  • Weighted average cost of debt is about 8.5%, with possible incremental increases of 0.5% due to rating changes.
  • No mention of equity fundraising during the call.

See what Bodal Chemicals management said on order book — free account, 30 seconds.

Capex plans

No
  • The company has completed a major CAPEX for benzene derivatives of around Rs. 390 crores within the current year; most payments (about Rs. 30 crores) are pending.
  • No further CAPEX or expansion is planned for the next two years until business performance improves.
  • All future cash flows are expected to be utilized towards debt repayment rather than new capital investments.
  • The company is focusing on stabilizing and optimizing the newly set-up benzene derivatives plant with an installed capacity of 63,000 tons per annum, expecting significant revenue (~Rs. 320 crores) and better margins (12%-15%) from next year onwards.
  • Strategic actions include shutting down smaller, less profitable older units to save fixed overheads and improve margins.
  • The company is also evaluating non-core asset sales (including land and factory in Ahmedabad valued around Rs. 100 crores) to reduce debt.

Track Bodal Chemicals — get its next earnings analysis in your feed

How does Bodal Chemicals rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisBodal Chemicals
Rev 3Mar 1

How does Bodal Chemicals rank in Chemicals & Petrochemicals?

Compare Bodal Chemicals against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →